Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.21 USD
−208.38 M USD
1.70 M USD
236.67 M
About Autolus Therapeutics plc
Sector
Industry
CEO
Christian Martin Itin
Website
Headquarters
London
Founded
2018
FIGI
BBG00KVT05R6
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.